XML 83 R67.htm IDEA: XBRL DOCUMENT v3.6.0.2
Loans and Leases (Allowance For Loan And Lease Losses By Portfolio Segment) (Detail) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Financing Receivable, Allowance for Credit Losses [Roll Forward]                      
Balance, beginning of period       $ 174,990       $ 159,264 $ 174,990 $ 159,264 $ 152,573
Provision (benefit) charged to expense $ 12,500 $ 14,250 $ 14,000 15,600 $ 13,800 $ 13,000 $ 12,750 9,750 56,350 49,300 37,250
Losses charged off                 (46,912) (43,560) (44,426)
Recoveries                 9,892 9,986 13,867
Balance, end of period 194,320       174,990       194,320 174,990 159,264
Individually evaluated for impairment 18,593       22,204       18,593 22,204 25,301
Collectively evaluated for impairment 175,727       152,786       175,727 152,786 133,963
Individually evaluated for impairment 249,355       279,171       249,355 279,171 330,856
Collectively evaluated for impairment 16,777,233       15,392,564       16,777,233 15,392,564 13,569,169
Total Loans and Leases 17,026,588 [1],[2]       15,671,735 [1],[2]       17,026,588 [1],[2] 15,671,735 [1],[2] 13,900,025
Residential Portfolio Segment [Member]                      
Financing Receivable, Allowance for Credit Losses [Roll Forward]                      
Balance, beginning of period       25,876       25,452 25,876 25,452 23,027
Provision (benefit) charged to expense                 230 6,057 7,315
Losses charged off                 (4,636) (6,508) (6,214)
Recoveries                 1,756 875 1,324
Balance, end of period 23,226       25,876       23,226 25,876 25,452
Individually evaluated for impairment 8,090       10,364       8,090 10,364 12,094
Collectively evaluated for impairment 15,136       15,512       15,136 15,512 13,358
Individually evaluated for impairment 119,424       134,448       119,424 134,448 141,982
Collectively evaluated for impairment 4,135,258       3,926,553       4,135,258 3,926,553 3,367,193
Total Loans and Leases 4,254,682       4,061,001       4,254,682 4,061,001 3,509,175
Consumer Portfolio Segment [Member]                      
Financing Receivable, Allowance for Credit Losses [Roll Forward]                      
Balance, beginning of period       42,052       43,518 42,052 43,518 41,951
Provision (benefit) charged to expense                 18,507 11,847 17,224
Losses charged off                 (20,669) (17,679) (20,712)
Recoveries                 5,343 4,366 5,055
Balance, end of period 45,233       42,052       45,233 42,052 43,518
Individually evaluated for impairment 2,903       3,477       2,903 3,477 4,237
Collectively evaluated for impairment 42,330       38,575       42,330 38,575 39,281
Individually evaluated for impairment 45,719       48,425       45,719 48,425 50,249
Collectively evaluated for impairment 2,638,781       2,654,135       2,638,781 2,654,135 2,499,152
Total Loans and Leases 2,684,500       2,702,560       2,684,500 2,702,560 2,549,401
Commercial Portfolio Segment [Member]                      
Financing Receivable, Allowance for Credit Losses [Roll Forward]                      
Balance, beginning of period       59,977       47,068 59,977 47,068 46,655
Provision (benefit) charged to expense                 28,662 21,693 9,712
Losses charged off                 (18,360) (11,522) (13,668)
Recoveries                 1,626 2,738 4,369
Balance, end of period 71,905       59,977       71,905 59,977 47,068
Individually evaluated for impairment 7,422       5,197       7,422 5,197 2,710
Collectively evaluated for impairment 64,483       54,780       64,483 54,780 44,358
Individually evaluated for impairment 53,037       56,581       53,037 56,581 36,176
Collectively evaluated for impairment 4,887,894       4,259,418       4,887,894 4,259,418 3,713,094
Total Loans and Leases 4,940,931       4,315,999       4,940,931 4,315,999 3,749,270
Commercial Real Estate Portfolio Segment [Member]                      
Financing Receivable, Allowance for Credit Losses [Roll Forward]                      
Balance, beginning of period       41,598       37,148 41,598 37,148 36,754
Provision (benefit) charged to expense                 7,930 11,381 2,746
Losses charged off                 (2,682) (7,578) (3,237)
Recoveries                 631 647 885
Balance, end of period 47,477       41,598       47,477 41,598 37,148
Individually evaluated for impairment 169       3,163       169 3,163 6,232
Collectively evaluated for impairment 47,308       38,435       47,308 38,435 30,916
Individually evaluated for impairment 24,755       39,295       24,755 39,295 101,817
Collectively evaluated for impairment 4,486,091       3,952,354       4,486,091 3,952,354 3,452,611
Total Loans and Leases 4,510,846       3,991,649       4,510,846 3,991,649 3,554,428
Finance Leases Portfolio Segment [Member]                      
Financing Receivable, Allowance for Credit Losses [Roll Forward]                      
Balance, beginning of period       $ 5,487       $ 6,078 5,487 6,078 4,186
Provision (benefit) charged to expense                 1,021 (1,678) 253
Losses charged off                 (565) (273) (595)
Recoveries                 536 1,360 2,234
Balance, end of period 6,479       5,487       6,479 5,487 6,078
Individually evaluated for impairment 9       3       9 3 28
Collectively evaluated for impairment 6,470       5,484       6,470 5,484 6,050
Individually evaluated for impairment 6,420       422       6,420 422 632
Collectively evaluated for impairment 629,209       600,104       629,209 600,104 537,119
Total Loans and Leases $ 635,629       $ 600,526       $ 635,629 $ 600,526 $ 537,751
[1] At December 31, 2016, the Company had pledged $6.4 billion of eligible loans as collateral to support borrowing capacity at the FHLB of Boston and the FRB of Boston.
[2] Loans and leases include net deferred fees and net premiums and discounts of $17.3 million and $18.0 million at December 31, 2016 and December 31, 2015, respectively.